Pediatrics

Latest News

FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6

March 28th 2024

Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.

FDA Approves Rilpivirine For Treatment of HIV-1 in Pediatric Patients
FDA Approves Rilpivirine For Treatment of HIV-1 in Pediatric Patients

March 21st 2024

Pediatric Medical Spending on Mental Health Increased by 31% in 4-Year Period
Pediatric Medical Spending on Mental Health Increased by 31% in 4-Year Period

March 12th 2024

CGM Can Help Pregnant Patients With T1D Improve TIR, Outcomes
CGM Can Help Pregnant Patients With T1D Improve TIR, Outcomes

February 7th 2024

Increase in STIs Among Adolescents Witnessed During COVID-19 Pandemic
Increase in STIs Among Adolescents Witnessed During COVID-19 Pandemic

February 5th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.